Structural deficiencies in the Common External Tariff (CET) and the New National Drug Distribution Guidelines (NNDG) are threatening to close down Nigeria’s 150 pharmaceutical firms and cripple N300 billion worth of investment made so far in the sector, industry stakeholders have said.
The CET be
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
ODINAKA ANUDU
Nigeria's leading finance and market intelligence news report. Also home to expert opinion and commentary on politics, sports, lifestyle, and more
